Page last updated: 2024-08-24

plerixafor and Atrophy

plerixafor has been researched along with Atrophy in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Boltze, J; Campos, RMP; Conde, L; Didwischus, N; Mendez-Otero, R; Pimentel-Coelho, PM; Spiess, DA	1
Englund, E; Issazadeh-Navikas, S; Kuric, E; Liu, Y; Ruscher, K; Walter, HL; Wieloch, T	1

Other Studies

2 other study(ies) available for plerixafor and Atrophy

Article	Year
Subacute AMD3100 Treatment Is Not Efficient in Neonatal Hypoxic-Ischemic Rats. Stroke, 2022, Volume: 53, Issue:2 Topics: Animals; Animals, Newborn; Atrophy; Benzylamines; Brain; Cognitive Dysfunction; Cyclams; Endpoint Determination; Female; Hypoxia-Ischemia, Brain; Male; Maze Learning; Pregnancy; Psychomotor Performance; Rats; Rats, Wistar; Receptors, CXCR4; Sex Characteristics; Treatment Failure	2022
Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:8 Topics: Animals; Atrophy; Benzylamines; Blotting, Western; Brain; Brain Ischemia; Chemokine CXCL12; Cyclams; DNA; DNA Fragmentation; Down-Regulation; Environment; Flow Cytometry; Fluorescent Antibody Technique; Heterocyclic Compounds; Immunohistochemistry; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Rats; Rats, Inbred SHR; Receptors, CXCR4; Recovery of Function; Signal Transduction; Spleen; Stroke	2013

Article

Year

Subacute AMD3100 Treatment Is Not Efficient in Neonatal Hypoxic-Ischemic Rats.

Stroke, 2022, Volume: 53, Issue:2

Topics: Animals; Animals, Newborn; Atrophy; Benzylamines; Brain; Cognitive Dysfunction; Cyclams; Endpoint Determination; Female; Hypoxia-Ischemia, Brain; Male; Maze Learning; Pregnancy; Psychomotor Performance; Rats; Rats, Wistar; Receptors, CXCR4; Sex Characteristics; Treatment Failure

2022

Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:8

Topics: Animals; Atrophy; Benzylamines; Blotting, Western; Brain; Brain Ischemia; Chemokine CXCL12; Cyclams; DNA; DNA Fragmentation; Down-Regulation; Environment; Flow Cytometry; Fluorescent Antibody Technique; Heterocyclic Compounds; Immunohistochemistry; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Rats; Rats, Inbred SHR; Receptors, CXCR4; Recovery of Function; Signal Transduction; Spleen; Stroke

2013